The Revenue Formula When deals die
26 snips
Apr 30, 2024 The podcast discusses why deals are harder to close today, introduces the MEDDICC framework to diagnose performance, emphasizes the importance of identifying and working with champions, explores the journey from pain to metric, analyzes who signs the deal and how decisions are made, and highlights the qualitative insights in sales operations and revenue generation.
AI Snips
Chapters
Transcript
Episode notes
Hosts' Biking And Kids Warm-Up
- Tony and Mikkel open with casual banter about biking, kids, and rain to warm up the episode.
- This establishes a conversational tone before shifting to diagnosing why deals die.
Deals Die Late; Use MEDDICC As Diagnosis
- Deals are dying more now because a late-stage reviewer (often the CFO) can veto without prior engagement.
- MEDDICC reframes this problem as a diagnostic tool to find where deals fail in the buyer journey.
Test Champions By Requesting Access
- Test your champion by asking them to invite a decision-maker and assess whether they can actually open doors.
- If the champion refuses or can't, label them weak and expect the deal to likely die.